Literature DB >> 5547280

Immunological protecion against dixin toxicity.

D H Schmidt, V P Butler.   

Abstract

The lethal dose of digoxin was determined by administering 10 ml of a digoxin-saline solution to 26 nonimmunized rabbits through an ear vein over a 10 min period. Rabbits receiving less than 0.45 mg/kg digoxin showed no toxic effect, whereas all 15 rabbits that received 0.5 mg/kg developed an early arrhythmia and died within 1 hr. Moreover, eight rabbits which had been immunized with antigens unrelated to digoxin or injected with Freund's adjuvant mixture all died after receiving 0.6 mg/kg digoxin. Thus, it was concluded that 0.6 mg/kg digoxin was uniformly lethal in rabbits that had not been immunized or had received antigens unrelated to digoxin. By way of contrast, 17 rabbits immunized with a digoxin-albumin conjugate in complete Freund's adjuvant formed digoxin-specific antibodies and survived doses of digoxin varying between 0.6 and 0.9 mg/kg. In 10 rabbits immunized with digoxin-albumin conjugates, digoxin-specific antibody titers were determined following the administration of digoxin. There was a significant fall in antibody titer. This study indicates that rabbits protected by digoxin-specific antibodies suffer no acute adverse effects from an amount of digoxin which is uniformly lethal in nonimmunized rabbits and in rabbits immunized with other antigens.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5547280      PMCID: PMC292001          DOI: 10.1172/JCI106558

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin.

Authors:  T W Smith; V P Butler; E Haber
Journal:  Biochemistry       Date:  1970-01-20       Impact factor: 3.162

2.  Digoxin-specific antibodies.

Authors:  V P Butler; J P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1967-01       Impact factor: 11.205

3.  Biologically effective immunization against angiotensin.

Authors:  D E Oken; T U Biber
Journal:  Am J Physiol       Date:  1968-04

4.  Antibodies against folic acid. I. In vitro biophysical effect.

Authors:  S P Rothenberg; F Gizis; B Kamen
Journal:  J Lab Clin Med       Date:  1969-10

5.  Antibodies to serotonin.

Authors:  N S Ranadive; A H Sehon
Journal:  Can J Biochem       Date:  1967-11

6.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

7.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

8.  Neutralization of airway effects on bradykinin by antibodies.

Authors:  T R Davis; T L Goodfriend
Journal:  Am J Physiol       Date:  1969-07

9.  Digitalis-induced arrhythmias and their management.

Authors:  G V Irons; E S Orgain
Journal:  Prog Cardiovasc Dis       Date:  1966-05       Impact factor: 8.194

10.  Pyridoxal-specific antibodies obtained with a synthetic pyridoxal-polypeptide conjugate.

Authors:  H Ungar-Waron; M Sela
Journal:  Biochim Biophys Acta       Date:  1966-07-27
View more
  9 in total

1.  The reactivation of the proscillaridin-inhibited membrane ATPase by specific antibodies.

Authors:  U R Kleeberg; G G Belz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

2.  Monoclonal antibodies to T-2 toxin. In vitro neutralization of protein synthesis inhibition and protection of rats against lethal toxemia.

Authors:  G Feuerstein; J A Powell; A T Knower; K W Hunter
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

3.  Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.

Authors:  V P Butler; D H Schmidt; T W Smith; E Haber; B D Raynor; P Demartini
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

4.  Effects of digoxin-specific antibodies on accumulation and binding of digoxin by human erythrocytes.

Authors:  J D Gardner; D R Kilno; T J Swartz; V P Butler
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

5.  The electrophysiologic effects of low and high digoxin concentrations on isolated mammalian cardiac tissue: reversal by digoxin-specific antibody.

Authors:  W J Mandel; J T Bigger; V P Butler
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

6.  Ouabain-specific antibodies: immunochemical properties and reversal of Na + , K + -activated adenosine triphosphatase inhibition.

Authors:  T W Smith
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

7.  Reversal of digoxin toxicity with specific antibodies.

Authors:  D H Schmidt; V P Butler
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

8.  Reversal of ouabain and acetyl strophanthidin effects in normal and failing cardiac muscle by specific antibody.

Authors:  H K Gold; T W Smith
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

9.  Persistence of hapten-antibody complexes in the circulation of immunized animals after a single intravenous injection of hapten.

Authors:  D H Schmidt; B M Kaufman; V P Butler
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.